SG Americas Securities’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,900
Closed -$94K 3482
2026
Q1
$94K Sell
23,900
-19,300
-45% -$1.52M ﹤0.01% 2946
2025
Q4
$49K Hold
43,200
﹤0.01% 3359
2025
Q3
$188K Buy
43,200
+23,900
+124% +$1.78M ﹤0.01% 2780
2025
Q2
$111K Sell
19,300
-12,400
-39% -$863K ﹤0.01% 2592
2025
Q1
$83K Buy
31,700
+14,200
+81% +$1.22M ﹤0.01% 3101
2024
Q4
$26K Hold
17,500
﹤0.01% 2987
2024
Q3
$19K Hold
17,500
﹤0.01% 3349
2024
Q2
$66K Buy
+17,500
New +$1.43M ﹤0.01% 2631

Other funds holding GEHC

SG Americas Securities's GEHC Position: Q2 2026 in Review

SG Americas Securities reduced its GE HealthCare (GEHC) stake by 60% in Q2 2026, selling an estimated $28.8M and leaving 296,782 shares worth $19M. The position accounts for 0.01% of the portfolio, ranked #615.

SG Americas Securities first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $52.3M in Q1 2026. 1,231 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • SG Americas Securities held 296,782 shares of GE HealthCare worth $19M as of Q2 2026.
  • SG Americas Securities sold 437,991 GE HealthCare shares in Q2 2026, an estimated $28.8M.
  • GE HealthCare made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #615 holding.
  • SG Americas Securities first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • SG Americas Securities's GE HealthCare position peaked at $52.3M in Q1 2026.
  • 1,231 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.